This paper is in the following e-collection/theme issue:

Non-Randomized Studies (funded, non-eHealth) (169) Decision Support for Health Professionals (1538) Infectious Diseases (non-STD/STI) (1725)

Published on in Vol 12 (2023)

Preprints (earlier versions) of this paper are available at https://preprints.jmir.org/preprint/48183, first published .
Optimal Dosing and Timing of High-Dose Corticosteroid Therapy in Hospitalized Patients With COVID-19: Study Protocol for a Retrospective Observational Multicenter Study (SELECT)

Optimal Dosing and Timing of High-Dose Corticosteroid Therapy in Hospitalized Patients With COVID-19: Study Protocol for a Retrospective Observational Multicenter Study (SELECT)

Optimal Dosing and Timing of High-Dose Corticosteroid Therapy in Hospitalized Patients With COVID-19: Study Protocol for a Retrospective Observational Multicenter Study (SELECT)

Authors of this article:

Katrijn Daenen1, 2 Author Orcid Image ;   Jilske A Huijben1 Author Orcid Image ;   Anders Boyd3, 4, 5 Author Orcid Image ;   Lieuwe D J Bos6, 7 Author Orcid Image ;   Sara C M Stoof1 Author Orcid Image ;   Hugo van Willigen8 Author Orcid Image ;   Diederik A M P J Gommers1 Author Orcid Image ;   Hazra S Moeniralam9 Author Orcid Image ;   Corstiaan A den Uil10 Author Orcid Image ;   Nicole P Juffermans11, 12 Author Orcid Image ;   Merijn Kant13, 14 Author Orcid Image ;   Abraham J Valkenburg15 Author Orcid Image ;   Janesh Pillay16, 17 Author Orcid Image ;   David M P van Meenen6, 18 Author Orcid Image ;   Frederique Paulus6, 19 Author Orcid Image ;   Marcus J Schultz6, 7 Author Orcid Image ;   Virgil A S H Dalm20, 21 Author Orcid Image ;   Eric C M van Gorp2, 22 Author Orcid Image ;   Janke Schinkel8 Author Orcid Image ;   Henrik Endeman1 Author Orcid Image ;   PRoVENT- and PRoAcT-COVID Collaborative Group23
Article Authors Cited by (5) Tweetations (2) Metrics

Journals

  1. Basida B, Gravenstein S, DeVone F, Abul Y, Singh M, Nepaul A, Tariq N, Leeder C, Bayer T. Previous Steroid Use and Severity of COVID-19. Journal of the American Medical Directors Association 2023;24(10):1608 View
  2. Meybodi S, Rabori V, Salkhorde D, Jafari N, Zeinaly M, Mojodi E, Kesharwani P, Saberiyan M, Sahebkar A. Dexamethasone in COVID-19 treatment: Analyzing monotherapy and combination therapy approaches. Cytokine 2024;184:156794 View
  3. Surawattanawong T, Hiransuthikul A, Katasrila P, Hemachudha T, Saraya A. Comparison of intravenous immunoglobulin and plasma exchange in hospital-acquired infections of autoimmune encephalitis in a tertiary care center. Asian Biomedicine 2025;19(3):147 View
  4. Jagesar A, Smalbil L, Galea E, Struja T, Dam T, Hilders P, Otten M, Biesheuvel L, Girbes A, Thoral P, Hoogendoorn M, Elbers P. Causal deep learning to personalize medicine: Which intensive care patients with sepsis will benefit from corticosteroid therapy?. Journal of Intensive Medicine 2025 View
  5. Cheng E, Mirzaei A. Is COVID-19 infection an independent etiologic factor in osteonecrosis development beyond corticosteroid exposure?. Journal of Orthopaedics 2026;72:27 View